Profil
Ingrid Goldberg is currently working as an Investor Relations Contact at NovoCure Ltd.
Prior to this, she worked as a Director-Investor Relations at ABIOMED, Inc. from 2014 to 2019 and as a Vice President-Investor Relations at bluebird bio, Inc. from 2020 to 2021.
Postes actifs de Ingrid Goldberg
| Sociétés | Poste | Début |
|---|---|---|
| NOVOCURE LIMITED | Investor Relations Contact | 01/07/2021 |
Anciens postes connus de Ingrid Goldberg
| Sociétés | Poste | Fin |
|---|---|---|
| BLUEBIRD BIO, INC. | Investor Relations Contact | 01/06/2021 |
| ABIOMED, INC. | Investor Relations Contact | 01/12/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
